Sep 8, 2023 4:30 pm EDT TissueCypher® Provides Clinically-Impactful Risk Stratification in Patients with Barrett’s Esophagus
Sep 6, 2023 7:00 am EDT Castle Biosciences to Highlight Clinical Value of IDgenetix® Test at Psych Congress 2023
Aug 7, 2023 7:00 am EDT New Publication Highlights the Ability of the TissueCypher® Barrett’s Esophagus Test to Improve and Standardize the Clinical Management of Low-Grade Dysplasia in Patients with Barrett’s Esophagus
Aug 1, 2023 7:00 am EDT Castle Biosciences to Present at the Canaccord Genuity 43rd Annual Growth Conference
Jul 19, 2023 7:00 am EDT Castle Biosciences to Release Second Quarter 2023 Financial Results and Host Conference Call on Wednesday, Aug. 2
Jul 17, 2023 7:00 am EDT Castle Biosciences Honored as an Arizona Top Workplace for the Second Consecutive Year
Jul 7, 2023 7:00 am EDT Castle Biosciences to Present New DecisionDx®-SCC and DecisionDx®-Melanoma Data at the American Head & Neck Society’s (AHNS) 11th International Conference on Head and Neck Cancer
